Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 03, 2016		May 29, 2015
Cash flows from operating activities:
Net income	$ 498,381		$ 232,381
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and accretion	165,661		165,564
Stock-based compensation	177,879		168,860
Deferred income taxes	50,853		(25,431)
Unrealized losses (gains) on investments, net	5,387		(9,963)
Tax benefit from stock-based compensation	65,286		44,721
Excess Tax Benefit from stock-based compensation	(65,289)		(44,739)
Other non-cash items	(875)		(702)
Changes in operating assets and liabilities, net of acquired assets and assumed liabilities:
Trade receivables, net	8,622		91,267
Prepaid expenses and other current assets	(103,044)		(27,307)
Trade payables	(18,723)		(13,763)
Accrued expenses	(14,490)		(51,199)
Income taxes payable	24,872		60,994
Deferred revenue	191,722		63,816
Net cash provided by operating activities	986,242		654,499
Cash flows from investing activities:
Purchases of short-term investments	(1,126,282)		(679,378)
Maturities of short-term investments	366,442		174,139
Proceeds from sales of short-term investments	450,187		661,182
Acquisitions, net of cash acquired	(48,427)		(805,979)
Purchases of property and equipment	(99,959)		(71,276)
Purchases of long-term investments and other assets	(52,563)		(17,954)
Proceeds from sale of long-term investments	255		1,986
Net cash used for investing activities	(510,347)		(737,280)
Cash flows from financing activities:
Purchases of treasury stock	(375,000)		(400,000)
Proceeds from issuance of treasury stock	52,285		71,169
Cost of issuance of treasury stock	(207,833)		(161,955)
Excess tax benefits from stock-based compensation	65,289		44,739
Proceeds from debt issuance	0		989,280
Repayment of debt and capital lease obligations	(21)		(602,189)
Debt issuance costs	0		(7,871)
Net cash used for financing activities	(465,280)		(66,827)
Effect of foreign currency exchange rates on cash and cash equivalents	(796)		(11,645)
Net increase (decrease) in cash and cash equivalents	9,819		(161,253)
Cash and cash equivalents at beginning of period	876,560	[1]	1,117,400
Cash and cash equivalents at end of period	886,379		956,147
Supplemental disclosures:
Cash paid for income taxes, net of refunds	33,943		20,208
Cash paid for interest	33,946		23,806
Non-cash investing activities:
Issuance of common stock and stock awards assumed in business acquisitions	$ 0		$ 677

[1] The Condensed Consolidated Balance Sheet as of November 27, 2015 has been derived from the audited Consolidated Financial Statements at that date but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.